Notice: TimeXNet Web will be temporarily affected due to Human Genome Center server maintenance until February 21 (Wednesday) 09:00 JST.
Job Name:
LPS Response in Mouse WT BMDCs
Current Gene List:
Background List:
Whole Genome
Note: Only the top 1000 records are shown here
| Category | Term | Genes | Count | % | P-value | Benjamini |
|---|---|---|---|---|---|---|
| KEGG_PATHWAY | mmu05142:Chagas disease (American trypanosomiasis) | 73 | 5.9 | 2.4e-44 | 6.2e-42 | |
| KEGG_PATHWAY | mmu05200:Pathways in cancer | 150 | 12.1 | 1.3e-43 | 1.6e-41 | |
| KEGG_PATHWAY | mmu04668:TNF signaling pathway | 72 | 5.8 | 1.7e-40 | 1.4e-38 | |
| KEGG_PATHWAY | mmu05164:Influenza A | 89 | 7.2 | 1.9e-38 | 1.2e-36 | |
| KEGG_PATHWAY | mmu04380:Osteoclast differentiation | 75 | 6.0 | 1.2e-37 | 6.0e-36 | |
| KEGG_PATHWAY | mmu04630:Jak-STAT signaling pathway | 80 | 6.4 | 6.5e-37 | 2.8e-35 | |
| KEGG_PATHWAY | mmu04620:Toll-like receptor signaling pathway | 66 | 5.3 | 1.2e-36 | 4.3e-35 | |
| KEGG_PATHWAY | mmu04722:Neurotrophin signaling pathway | 72 | 5.8 | 8.5e-36 | 2.7e-34 | |
| KEGG_PATHWAY | mmu05161:Hepatitis B | 78 | 6.3 | 1.1e-34 | 3.2e-33 | |
| KEGG_PATHWAY | mmu05169:Epstein-Barr virus infection | 96 | 7.7 | 1.9e-34 | 4.8e-33 | |
| KEGG_PATHWAY | mmu05205:Proteoglycans in cancer | 92 | 7.4 | 1.3e-33 | 2.9e-32 | |
| KEGG_PATHWAY | mmu04660:T cell receptor signaling pathway | 64 | 5.1 | 2.7e-33 | 5.8e-32 | |
| KEGG_PATHWAY | mmu05162:Measles | 73 | 5.9 | 1.3e-32 | 2.6e-31 | |
| KEGG_PATHWAY | mmu05160:Hepatitis C | 73 | 5.9 | 1.3e-32 | 2.6e-31 | |
| KEGG_PATHWAY | mmu05145:Toxoplasmosis | 66 | 5.3 | 2.1e-32 | 3.8e-31 | |
| KEGG_PATHWAY | mmu04010:MAPK signaling pathway | 102 | 8.2 | 4.7e-32 | 8.0e-31 | |
| KEGG_PATHWAY | mmu04012:ErbB signaling pathway | 57 | 4.6 | 1.0e-31 | 1.7e-30 | |
| KEGG_PATHWAY | mmu05220:Chronic myeloid leukemia | 51 | 4.1 | 8.0e-31 | 1.2e-29 | |
| KEGG_PATHWAY | mmu04510:Focal adhesion | 89 | 7.2 | 2.1e-30 | 3.0e-29 | |
| KEGG_PATHWAY | mmu04151:PI3K-Akt signaling pathway | 120 | 9.7 | 8.0e-30 | 1.1e-28 | |
| KEGG_PATHWAY | mmu04917:Prolactin signaling pathway | 50 | 4.0 | 3.8e-29 | 4.8e-28 | |
| KEGG_PATHWAY | mmu05166:HTLV-I infection | 103 | 8.3 | 8.9e-29 | 1.1e-27 | |
| KEGG_PATHWAY | mmu04062:Chemokine signaling pathway | 84 | 6.8 | 1.4e-28 | 1.7e-27 | |
| KEGG_PATHWAY | mmu04015:Rap1 signaling pathway | 88 | 7.1 | 2.3e-28 | 2.6e-27 | |
| KEGG_PATHWAY | mmu04068:FoxO signaling pathway | 67 | 5.4 | 1.5e-27 | 1.6e-26 | |
| KEGG_PATHWAY | mmu05212:Pancreatic cancer | 45 | 3.6 | 1.6e-26 | 1.6e-25 | |
| KEGG_PATHWAY | mmu04664:Fc epsilon RI signaling pathway | 46 | 3.7 | 1.9e-26 | 1.8e-25 | |
| KEGG_PATHWAY | mmu05203:Viral carcinogenesis | 89 | 7.2 | 3.0e-26 | 2.8e-25 | |
| KEGG_PATHWAY | mmu04064:NF-kappa B signaling pathway | 55 | 4.4 | 4.0e-26 | 3.6e-25 | |
| KEGG_PATHWAY | mmu04650:Natural killer cell mediated cytotoxicity | 57 | 4.6 | 8.7e-26 | 7.7e-25 | |
| KEGG_PATHWAY | mmu05152:Tuberculosis | 75 | 6.0 | 2.5e-25 | 2.2e-24 | |
| KEGG_PATHWAY | mmu05133:Pertussis | 47 | 3.8 | 2.8e-25 | 2.3e-24 | |
| KEGG_PATHWAY | mmu04210:Apoptosis | 42 | 3.4 | 4.9e-25 | 3.9e-24 | |
| KEGG_PATHWAY | mmu05215:Prostate cancer | 51 | 4.1 | 7.9e-25 | 6.1e-24 | |
| KEGG_PATHWAY | mmu05223:Non-small cell lung cancer | 40 | 3.2 | 2.4e-24 | 1.8e-23 | |
| KEGG_PATHWAY | mmu04014:Ras signaling pathway | 84 | 6.8 | 4.1e-23 | 3.0e-22 | |
| KEGG_PATHWAY | mmu04060:Cytokine-cytokine receptor interaction | 87 | 7.0 | 7.8e-23 | 5.5e-22 | |
| KEGG_PATHWAY | mmu04910:Insulin signaling pathway | 62 | 5.0 | 5.1e-22 | 3.5e-21 | |
| KEGG_PATHWAY | mmu05214:Glioma | 41 | 3.3 | 6.8e-22 | 4.6e-21 | |
| KEGG_PATHWAY | mmu04370:VEGF signaling pathway | 39 | 3.1 | 1.7e-21 | 1.1e-20 | |
| KEGG_PATHWAY | mmu04662:B cell receptor signaling pathway | 42 | 3.4 | 2.9e-21 | 1.9e-20 | |
| KEGG_PATHWAY | mmu04071:Sphingolipid signaling pathway | 57 | 4.6 | 3.2e-21 | 2.0e-20 | |
| KEGG_PATHWAY | mmu05140:Leishmaniasis | 40 | 3.2 | 3.7e-21 | 2.3e-20 | |
| KEGG_PATHWAY | mmu04915:Estrogen signaling pathway | 50 | 4.0 | 4.2e-21 | 2.5e-20 | |
| KEGG_PATHWAY | mmu05222:Small cell lung cancer | 46 | 3.7 | 4.7e-21 | 2.8e-20 | |
| KEGG_PATHWAY | mmu05168:Herpes simplex infection | 76 | 6.1 | 8.0e-21 | 4.6e-20 | |
| KEGG_PATHWAY | mmu05210:Colorectal cancer | 39 | 3.1 | 4.4e-20 | 2.4e-19 | |
| KEGG_PATHWAY | mmu04622:RIG-I-like receptor signaling pathway | 39 | 3.1 | 8.1e-19 | 4.4e-18 | |
| KEGG_PATHWAY | mmu04919:Thyroid hormone signaling pathway | 51 | 4.1 | 1.3e-18 | 7.0e-18 | |
| KEGG_PATHWAY | mmu04621:NOD-like receptor signaling pathway | 35 | 2.8 | 1.6e-18 | 8.2e-18 | |
| KEGG_PATHWAY | mmu04611:Platelet activation | 55 | 4.4 | 2.7e-18 | 1.4e-17 | |
| KEGG_PATHWAY | mmu04670:Leukocyte transendothelial migration | 52 | 4.2 | 7.5e-18 | 3.8e-17 | |
| KEGG_PATHWAY | mmu04914:Progesterone-mediated oocyte maturation | 43 | 3.5 | 1.5e-17 | 7.5e-17 | |
| KEGG_PATHWAY | mmu05213:Endometrial cancer | 32 | 2.6 | 1.1e-16 | 5.6e-16 | |
| KEGG_PATHWAY | mmu05221:Acute myeloid leukemia | 33 | 2.7 | 2.0e-16 | 1.0e-15 | |
| KEGG_PATHWAY | mmu04066:HIF-1 signaling pathway | 46 | 3.7 | 2.0e-16 | 1.0e-15 | |
| KEGG_PATHWAY | mmu05132:Salmonella infection | 39 | 3.1 | 3.6e-16 | 1.6e-15 | |
| KEGG_PATHWAY | mmu04912:GnRH signaling pathway | 41 | 3.3 | 1.5e-15 | 6.4e-15 | |
| KEGG_PATHWAY | mmu05231:Choline metabolism in cancer | 43 | 3.5 | 1.3e-14 | 5.9e-14 | |
| KEGG_PATHWAY | mmu05100:Bacterial invasion of epithelial cells | 37 | 3.0 | 2.2e-14 | 9.3e-14 | |
| KEGG_PATHWAY | mmu04923:Regulation of lipolysis in adipocytes | 31 | 2.5 | 3.8e-14 | 1.6e-13 | |
| KEGG_PATHWAY | mmu04810:Regulation of actin cytoskeleton | 66 | 5.3 | 6.7e-14 | 2.8e-13 | |
| KEGG_PATHWAY | mmu04931:Insulin resistance | 44 | 3.5 | 8.8e-14 | 3.6e-13 | |
| KEGG_PATHWAY | mmu04930:Type II diabetes mellitus | 28 | 2.3 | 3.3e-13 | 1.3e-12 | |
| KEGG_PATHWAY | mmu04666:Fc gamma R-mediated phagocytosis | 37 | 3.0 | 3.6e-13 | 1.4e-12 | |
| KEGG_PATHWAY | mmu04024:cAMP signaling pathway | 60 | 4.8 | 2.0e-12 | 7.7e-12 | |
| KEGG_PATHWAY | mmu05146:Amoebiasis | 43 | 3.5 | 4.9e-12 | 1.9e-11 | |
| KEGG_PATHWAY | mmu05202:Transcriptional misregulation in cancer | 53 | 4.3 | 6.3e-12 | 2.4e-11 | |
| KEGG_PATHWAY | mmu05321:Inflammatory bowel disease (IBD) | 29 | 2.3 | 7.5e-12 | 2.8e-11 | |
| KEGG_PATHWAY | mmu05211:Renal cell carcinoma | 31 | 2.5 | 8.6e-12 | 3.2e-11 | |
| KEGG_PATHWAY | mmu04261:Adrenergic signaling in cardiomyocytes | 49 | 3.9 | 1.8e-11 | 6.5e-11 | |
| KEGG_PATHWAY | mmu05134:Legionellosis | 28 | 2.3 | 1.9e-11 | 6.8e-11 | |
| KEGG_PATHWAY | mmu04932:Non-alcoholic fatty liver disease (NAFLD) | 50 | 4.0 | 3.0e-11 | 1.1e-10 | |
| KEGG_PATHWAY | mmu05218:Melanoma | 31 | 2.5 | 5.2e-11 | 1.8e-10 | |
| KEGG_PATHWAY | mmu05219:Bladder cancer | 23 | 1.9 | 6.2e-11 | 2.1e-10 | |
| KEGG_PATHWAY | mmu04110:Cell cycle | 42 | 3.4 | 1.7e-10 | 6.0e-10 | |
| KEGG_PATHWAY | mmu04640:Hematopoietic cell lineage | 33 | 2.7 | 3.0e-10 | 1.0e-9 | |
| KEGG_PATHWAY | mmu04520:Adherens junction | 30 | 2.4 | 4.4e-10 | 1.5e-9 | |
| KEGG_PATHWAY | mmu04540:Gap junction | 33 | 2.7 | 6.1e-10 | 2.0e-9 | |
| KEGG_PATHWAY | mmu04921:Oxytocin signaling pathway | 47 | 3.8 | 1.6e-9 | 5.2e-9 | |
| KEGG_PATHWAY | mmu04550:Signaling pathways regulating pluripotency of stem cells | 43 | 3.5 | 1.9e-9 | 6.0e-9 | |
| KEGG_PATHWAY | mmu04920:Adipocytokine signaling pathway | 29 | 2.3 | 2.3e-9 | 7.2e-9 | |
| KEGG_PATHWAY | mmu04960:Aldosterone-regulated sodium reabsorption | 21 | 1.7 | 2.4e-9 | 7.5e-9 | |
| KEGG_PATHWAY | mmu05230:Central carbon metabolism in cancer | 27 | 2.2 | 2.8e-9 | 8.7e-9 | |
| KEGG_PATHWAY | mmu04750:Inflammatory mediator regulation of TRP channels | 40 | 3.2 | 4.2e-9 | 1.3e-8 | |
| KEGG_PATHWAY | mmu04152:AMPK signaling pathway | 40 | 3.2 | 5.4e-9 | 1.6e-8 | |
| KEGG_PATHWAY | mmu04022:cGMP-PKG signaling pathway | 47 | 3.8 | 2.5e-8 | 7.4e-8 | |
| KEGG_PATHWAY | mmu04728:Dopaminergic synapse | 40 | 3.2 | 2.9e-8 | 8.4e-8 | |
| KEGG_PATHWAY | mmu04115:p53 signaling pathway | 26 | 2.1 | 4.4e-8 | 1.3e-7 | |
| KEGG_PATHWAY | mmu05014:Amyotrophic lateral sclerosis (ALS) | 22 | 1.8 | 7.2e-8 | 2.1e-7 | |
| KEGG_PATHWAY | mmu04623:Cytosolic DNA-sensing pathway | 25 | 2.0 | 7.3e-8 | 2.1e-7 | |
| KEGG_PATHWAY | mmu04360:Axon guidance | 38 | 3.1 | 9.9e-8 | 2.8e-7 | |
| KEGG_PATHWAY | mmu04144:Endocytosis | 63 | 5.1 | 2.1e-7 | 5.9e-7 | |
| KEGG_PATHWAY | mmu04150:mTOR signaling pathway | 23 | 1.9 | 2.9e-7 | 7.9e-7 | |
| KEGG_PATHWAY | mmu05340:Primary immunodeficiency | 17 | 1.4 | 2.9e-7 | 7.9e-7 | |
| KEGG_PATHWAY | mmu05143:African trypanosomiasis | 17 | 1.4 | 4.7e-7 | 1.3e-6 | |
| KEGG_PATHWAY | mmu04114:Oocyte meiosis | 33 | 2.7 | 5.1e-7 | 1.4e-6 | |
| KEGG_PATHWAY | mmu04730:Long-term depression | 23 | 1.9 | 5.7e-7 | 1.5e-6 | |
| KEGG_PATHWAY | mmu04350:TGF-beta signaling pathway | 28 | 2.3 | 5.8e-7 | 1.5e-6 | |
| KEGG_PATHWAY | mmu05144:Malaria | 20 | 1.6 | 6.3e-7 | 1.6e-6 | |
| KEGG_PATHWAY | mmu04530:Tight junction | 38 | 3.1 | 7.8e-7 | 2.0e-6 | |
| KEGG_PATHWAY | mmu04725:Cholinergic synapse | 33 | 2.7 | 9.9e-7 | 2.5e-6 | |
| KEGG_PATHWAY | mmu03050:Proteasome | 19 | 1.5 | 1.0e-6 | 2.6e-6 | |
| KEGG_PATHWAY | mmu04120:Ubiquitin mediated proteolysis | 38 | 3.1 | 1.4e-6 | 3.4e-6 | |
| KEGG_PATHWAY | mmu05020:Prion diseases | 15 | 1.2 | 4.8e-6 | 1.2e-5 | |
| KEGG_PATHWAY | mmu04141:Protein processing in endoplasmic reticulum | 41 | 3.3 | 6.0e-6 | 1.5e-5 | |
| KEGG_PATHWAY | mmu05323:Rheumatoid arthritis | 25 | 2.0 | 1.2e-5 | 2.9e-5 | |
| KEGG_PATHWAY | mmu05414:Dilated cardiomyopathy | 25 | 2.0 | 1.5e-5 | 3.6e-5 | |
| KEGG_PATHWAY | mmu04390:Hippo signaling pathway | 37 | 3.0 | 1.7e-5 | 4.0e-5 | |
| KEGG_PATHWAY | mmu05206:MicroRNAs in cancer | 57 | 4.6 | 1.8e-5 | 4.1e-5 | |
| KEGG_PATHWAY | mmu05030:Cocaine addiction | 18 | 1.4 | 2.0e-5 | 4.6e-5 | |
| KEGG_PATHWAY | mmu05416:Viral myocarditis | 24 | 1.9 | 2.0e-5 | 4.6e-5 | |
| KEGG_PATHWAY | mmu04720:Long-term potentiation | 21 | 1.7 | 3.6e-5 | 8.3e-5 | |
| KEGG_PATHWAY | mmu05216:Thyroid cancer | 13 | 1.0 | 4.5e-5 | 0.0001 | |
| KEGG_PATHWAY | mmu05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 21 | 1.7 | 0.00011 | 0.00026 | |
| KEGG_PATHWAY | mmu04612:Antigen processing and presentation | 23 | 1.9 | 0.00012 | 0.00026 | |
| KEGG_PATHWAY | mmu04916:Melanogenesis | 25 | 2.0 | 0.00032 | 0.00071 | |
| KEGG_PATHWAY | mmu04145:Phagosome | 37 | 3.0 | 0.00037 | 0.00082 | |
| KEGG_PATHWAY | mmu05150:Staphylococcus aureus infection | 16 | 1.3 | 0.00038 | 0.00083 | |
| KEGG_PATHWAY | mmu05031:Amphetamine addiction | 19 | 1.5 | 0.00047 | 0.001 | |
| KEGG_PATHWAY | mmu04270:Vascular smooth muscle contraction | 29 | 2.3 | 0.00057 | 0.0012 | |
| KEGG_PATHWAY | mmu04672:Intestinal immune network for IgA production | 14 | 1.1 | 0.00067 | 0.0014 | |
| KEGG_PATHWAY | mmu04310:Wnt signaling pathway | 31 | 2.5 | 0.00069 | 0.0014 | |
| KEGG_PATHWAY | mmu04320:Dorso-ventral axis formation | 10 | 0.8 | 0.0014 | 0.0028 | |
| KEGG_PATHWAY | mmu05410:Hypertrophic cardiomyopathy (HCM) | 20 | 1.6 | 0.0014 | 0.003 | |
| KEGG_PATHWAY | mmu04940:Type I diabetes mellitus | 17 | 1.4 | 0.0015 | 0.0031 | |
| KEGG_PATHWAY | mmu04713:Circadian entrainment | 23 | 1.9 | 0.0017 | 0.0034 | |
| KEGG_PATHWAY | mmu04925:Aldosterone synthesis and secretion | 21 | 1.7 | 0.0017 | 0.0034 | |
| KEGG_PATHWAY | mmu04973:Carbohydrate digestion and absorption | 13 | 1.0 | 0.0023 | 0.0046 | |
| KEGG_PATHWAY | mmu05034:Alcoholism | 38 | 3.1 | 0.0032 | 0.0063 | |
| KEGG_PATHWAY | mmu05330:Allograft rejection | 15 | 1.2 | 0.004 | 0.0079 | |
| KEGG_PATHWAY | mmu04020:Calcium signaling pathway | 34 | 2.7 | 0.0051 | 0.01 | |
| KEGG_PATHWAY | mmu05332:Graft-versus-host disease | 14 | 1.1 | 0.0055 | 0.011 | |
| KEGG_PATHWAY | mmu04971:Gastric acid secretion | 17 | 1.4 | 0.0076 | 0.015 | |
| KEGG_PATHWAY | mmu04330:Notch signaling pathway | 13 | 1.0 | 0.0089 | 0.017 | |
| KEGG_PATHWAY | mmu04512:ECM-receptor interaction | 19 | 1.5 | 0.012 | 0.022 | |
| KEGG_PATHWAY | mmu04918:Thyroid hormone synthesis | 16 | 1.3 | 0.013 | 0.025 | |
| KEGG_PATHWAY | mmu04723:Retrograde endocannabinoid signaling | 21 | 1.7 | 0.014 | 0.026 | |
| KEGG_PATHWAY | mmu04970:Salivary secretion | 17 | 1.4 | 0.014 | 0.027 | |
| KEGG_PATHWAY | mmu04924:Renin secretion | 15 | 1.2 | 0.032 | 0.059 | |
| KEGG_PATHWAY | mmu04514:Cell adhesion molecules (CAMs) | 28 | 2.3 | 0.034 | 0.061 | |
| KEGG_PATHWAY | mmu04961:Endocrine and other factor-regulated calcium reabsorption | 12 | 1.0 | 0.034 | 0.062 | |
| KEGG_PATHWAY | mmu04724:Glutamatergic synapse | 21 | 1.7 | 0.042 | 0.075 | |
| KEGG_PATHWAY | mmu04913:Ovarian steroidogenesis | 12 | 1.0 | 0.062 | 0.11 | |
| KEGG_PATHWAY | mmu04922:Glucagon signaling pathway | 18 | 1.4 | 0.069 | 0.12 | |
| KEGG_PATHWAY | mmu05032:Morphine addiction | 17 | 1.4 | 0.07 | 0.12 | |
| KEGG_PATHWAY | mmu04911:Insulin secretion | 16 | 1.3 | 0.07 | 0.12 |